Friday, July 10, 2026

pharma · Alopecia areata · Multiple myeloma

First Biotech (Australia)

Pfizer Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosi

Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
Status
Public
HQ
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
Founded
2017
Employees
2
Programs
126
Drugs
208
Patents
0
Clinical program

LORLATINIB

Approved · small molecule · Lung cancer

LORLATINIB for Lung cancer is a Approved program (small_molecule) at Pfizer Australia Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Pfizer Australia Pty Ltd projects Approved small molecule active

Internal code B7461039

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer Australia Pty Ltd
Phase
Approved
Modality
small_molecule
Indication
Lung cancer
Status
active
Trials
1